Stock Market & Financial Investment News

News Breaks March 6, 2013 07:33 EDT INFI Infinity Pharmaceuticals price target raised to $55 from $38 at RBC Capital RBC Capital expects Infiinity's stock to be pushed higher by favorable data at ASCO/ASH. The firm thinks the stock's valuation is attractive, and it maintains an Outperform rating on the shares. News For INFI From The Last 14 Days Check below for free stories on INFI the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 17, 2013 07:26 EDT INFI Infinity Pharmaceuticals sell-off excessive, says Wells Fargo Subscribe for More Information May 16, 2013 12:07 EDT INFI Options with increasing implied volatility: INFI WCRX SODA LYV HYG 12:00 EDT INFI Infinity Pharmaceuticals falls 19.5% Subscribe for More Information 07:29 EDT INFI Leerink to host a bus tour Boston Biopharma Bus Tour travels throughout Boston on May 16-17. May 9, 2013 10:08 EDT INFI On The Fly: Analyst Initiation Summary Today's noteworthy initiations include: Chicago Bridge & Iron (CBI) initiated with a Buy at Deutsche Bank... Fluor (FLR) initiated with a Buy at Deutsche Bank... Infinity Pharmaceuticals (INFI) initiated with an Outperform at Wells Fargo... Jacobs Engineering (JEC) initiated with a Hold at Deutsche Bank... KBR (KBR) initiated with a Buy at Deutsche Bank... MasTec (MTZ) initiated with a Buy at Deutsche Bank... McDermott (MDR) initiated with a Hold at Deutsche Bank... Merit Medical (MMSI) initiated with a Hold at Benchmark Co... Ocean Power (OPTT) initiated with a Strong Buy at Ascendiant Capital... Quanta Services (PWR) initiated with a Buy at Deutsche Bank... ZELTIQ Aesthetics (ZLTQ) initiated with a Buy at Maxim... Evercore Partners (EVR) initiated with a Positive at Susquehanna... Alexander & Baldwin (ALEX) initiated with an Outperform at JMP Securities... Myriad Genetics (MYGN) coverage resumed with an Overweight at Stephens... Pinnacle Foods (PF) initiated with a Buy at Janney Capital. 05:38 EDT INFI Infinity Pharmaceuticals initiated with an Outperform at Wells Fargo Price target range $48-$50. May 7, 2013 16:13 EDT INFI Infinity Pharmaceuticals says Phase l data for IPI-145 to be presented at ASCO Subscribe for More Information 16:11 EDT INFI Infinity Pharmaceuticals reports Q1 EPS (57c) , consensus (67c) Subscribe for More Information 06:22 EDT INFI Infinity Pharmaceuticals initiated with a Neutral at Goldman Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.